Burlingame, CA, April 17, 2025 (GLOBE NEWSWIRE) — Coherent Market Insights published a report, titled, ” Typhoid Fever Vaccines Market, by Vaccine Type (Live Attenuated Vaccine, Capsular Polysaccharide Vaccines, Conjugate Vaccine, and Others), by Route of Administration (Oral and Parental): Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030″. According to the report, the global typhoid fever vaccines market size was valued at $351.4 million in 2022, and is projected to reach $884.8 million by 2030, growing at a CAGR of 12.2% from 2022 to 2030.
Request a Sample of the US Tariff Impact Analysis Report: https://www.coherentmarketinsights.com/insight/request-sample/2552
Global Typhoid Fever Vaccines Market Key Takeaways
The global fever vaccines market is projected to record a CAGR of 12.2% over the forecast period, totaling US$ 884.4 million by 2030.
By vaccine type, capsular polysaccharide vaccines segment is anticipated to retain its dominance during the assessment period. It accounted for about 54.8% of the global typhoid fever vaccines market share in 2022.
As per Coherent Market Insights, Africa leads from the forefront when it comes to typhoid fever vaccine market demand. The region accounted for a prominent 18.8% share of the typhoid fever vaccines market in 2022.
Asia Pacific typhoid fever vaccines market is anticipated to witness strong growth on the back of rising typhoid incidence and favourable government immunization initiatives.
North America accounts for the second-largest market share, as per Coherent Market Insights typhoid fever vaccines market latest research.
Increasing Typhoid Fever Burden Fueling Market Growth
A new report by Coherent Market Insights outlines significant typhoid fever vaccines market trends. One such trend expected to fuel growth of typhoid fever vaccines industry is the increasing prevalence of typhoid globally.
Cases of typhoid fever are increasing rapidly, especially in developing and underdeveloped nations. According to the World Health Organization (WHO), around 9 million people are affected by typhoid fever each year, leading to approximately 110,000 deaths annually.
The alarming rise in typhoid fever cases and mortality rates is fueling demand for typhoid fever vaccines, and the trend will likely continue in the coming years. People are gradually becoming more aware of the risks associated with untreated typhoid fever. This growing awareness is expected to play a key role in accelerating typhoid fever vaccine …